PF-3512676

Search structure
Status: Phase 3
Entry Type: Oligonucleotide
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Malaria Phase 1 ClinicalTrials
Lymphoma; Lymphoma, Non-Hodgkin; Mycoses; Mycosis Fungoides Phase 1/Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 3 ClinicalTrials
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid Phase 1 ClinicalTrials
Lymphoma; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Phase 1/Phase 2 ClinicalTrials
Sepsis; Toxemia Phase 1 ClinicalTrials
Lymphoma; Lymphoma, Mantle-Cell Phase 2 ClinicalTrials
Carcinoma; Carcinoma, Renal Cell Phase 1/Phase 2 ClinicalTrials
Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Lymphoma, T-Cell Phase 2 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Mycoses; Mycosis Fungoides Phase 1/Phase 2 ClinicalTrials
Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin Phase 2 ClinicalTrials
CONTENTS